Apricus Biosciences Announces Appointment of Paul V. Maier to Its Board of Directors

SAN DIEGO, June 4, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (“Apricus Bio”) (Nasdaq:APRI) (www.apricusbio.com) today announced that Paul V. Maier, Chief Financial Officer of Sequenom, Inc., has been appointed to the Company’s Board of Directors, effective June 1, 2012.

MORE ON THIS TOPIC